Jonathan Piazza

Jonathan Piazza has a strong background in finance and investment banking. Jonathan is currently serving as the Chief Financial Officer at Orbital Therapeutics, a position they started in January 2023. Prior to this, Jonathan held the same role at Silverback Therapeutics from November 2020 to September 2022. Before transitioning to the biotech industry, they worked at Goldman Sachs as a Managing Director in Healthcare Investment Banking from October 2018 to November 2020. Prior to that, they worked at Barclays Investment Bank in the same role from September 2008 to October 2018. Jonathan'sexperience in investment banking started at Lehman Brothers, where they worked as an Associate in Healthcare Investment Banking from August 2005 to September 2008. Jonathan also has experience as a Financial Advisor at Smith Barney from March 2001 to May 2003. Jonathan initially started their career at Abbott Laboratories, where they worked as a Chemical Engineer in their Professional Development Program from June 1998 to March 2001.

Jonathan Piazza completed their education at two prestigious institutions. From 1993 to 1998, they attended The Ohio State University, where they pursued a Bachelor of Science degree in Chemical Engineering. Following that, they enrolled at the University of California, Berkeley, Haas School of Business from 2003 to 2005 to obtain an MBA with a focus on Business.